PROTEOMICS INTERNATIONAL LABORATORIES L news, videos and press releases
For more news please use our advanced search feature.
PROTEOMICS INTERNATIONAL LABORATORIES L - More news...
PROTEOMICS INTERNATIONAL LABORATORIES L - More news...
- Proteomics International Laboratories Ltd (PIQ.AX) March 2024 Quarterly Activities Report
- Proteomics International Laboratories Ltd (PIQ.AX) Investor Presentation
- Proteomics International Laboratories Ltd (PIQ.AX) Signs With Oxford University to Validate Test for Endometriosis
- Proteomics International Laboratories Ltd (PIQ.AX) PromarkerD US Commercialisation and Promarker Pipeline Update
- Proteomics International Laboratories Ltd (PIQ.AX) Retains its ISO13485 Certification
- Proteomics International Laboratories Ltd (PIQ.AX) European Patent Granted for OxiDx Technology
- Proteomics International Laboratories Ltd (PIQ.AX) Investor presentation - Euroz Hartleys Healthcare Forum
- Proteomics International Laboratories Ltd (PIQ.AX) Study Validates Biomarkers for Endometriosis Blood Test
- Proteomics International Laboratories Ltd (PIQ.AX) Study Validates Biomarkers for Oesophageal Cancer Blood Test
- Proteomics International Laboratories Ltd (PIQ.AX) December 2023 Quarterly Activities Report
- Proteomics International Laboratories Ltd (PIQ.AX) To Raise $6.5m Through Institutional Placement
- Proteomics International Laboratories Ltd (PIQ.AX) PromarkerD Licence with Omics Global Extended to Chile
- Proteomics International Laboratories Ltd (PIQ.AX) AGM Chairman's Address and Investor Presentation
- Proteomics International Laboratories Ltd (PIQ.AX) US Medicare Confirms Reimbursement Price for PromarkerD
- Proteomics International Laboratories Ltd (PIQ.AX) Presents at Bell Potter Healthcare Conference
- Proteomics International Laboratories Ltd (PIQ.AX) Investor Presentation
- Proteomics International Laboratories Ltd (PIQ.AX) September 2023 Quarterly Activities Report
- Proteomics International Laboratories Ltd (PIQ.AX) New Oesophageal Cancer Test Presented at Global Conference
- Proteomics International Laboratories Ltd (PIQ.AX) OxiDx Platform Technology Secures Patent in Japan
- Proteomics International Laboratories Ltd (PIQ.AX) Annual Report to Shareholders
- Proteomics International Laboratories Ltd (PIQ.AX) Proteomics Presents at 17th Bioshares Biotech Summit
- Proteomics International Laboratories Ltd (PIQ.AX) June 2023 Quarterly Activities Report
- Proteomics International Laboratories Ltd (PIQ.AX) Promarker Pipeline - Oesophageal Cancer Diagnostic Update
- VIDEO: Proteomics International Laboratories Limited (PIQ.AX) MD Dr. Richard Lipscombe Talks about the PromarkerD Test and Agreement with Sonic Healthcare
- Proteomics International Laboratories Ltd (PIQ.AX) Sonic Healthcare USA Signs Licence for PromarkerD in the US
- Proteomics International Laboratories Ltd (PIQ.AX) World Endometriosis Congress - New Diagnostic Test Showcased
- Proteomics International Laboratories Ltd (PIQ.AX) Diabetes Drug, Canagliflozin, Lowers PromarkerD Diabetic Kidney Disease Risk Prediction Scores
- Proteomics International Laboratories Ltd (PIQ.AX) Canagliflozin Lowers PromarkerD DKD Risk Prediction Scores
- Proteomics International Laboratories Ltd (PIQ.AX) March 2023 Quarterly Activities Report
- Proteomics International Laboratories Ltd (PIQ.AX) Clinical Advisory Board Expanded for PromarkerD USA Rollout